Compare Crescent Energy Company Class A Common Stock (CRGY) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs Eli Lilly And Co — how do they compare? Crescent Energy Company Class A Common Stock trades at $12.81 (market cap $4.30B), while Eli Lilly And Co trades at $1,175.62 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 241.9× Crescent Energy Company Class A Common Stock's market cap, and Crescent Energy Company Class A Common Stock pays the higher dividend (3.69%). Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 0 Days and Eli Lilly And Co for 93 Days on average.
| CRGY | LLY | |
|---|---|---|
Market Cap | $4.30B | $1.04T |
Volume | 15,201,625 | 3,064,878 |
Sector | Energy | Health |
52-Week High | $15.37 | $1.28K |
52-Week Low | $7.75 | $799.57 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $9.31B | $1.09T |
Dividend Yield | 3.69% | 0.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
